Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
abandon, Accuray, adenocarcinoma, ADHH, autosomal, Belgium, bioengineered, bound, burden, CAC, California, CDER, Centocor, clarification, clearance, concept, customary, disagree, dominant, engineer, Engineering, environment, Eric, expensesprimarily, extracellular, formula, Fournier, frame, France, Genzyme, greatly, HGT, Hodgkin, hydration, infusion, largest, lung, MAA, Mayo, metastatic, mouse, multi, mutation, Natpara, Newark, NOL, oncology, ordinary, Organon, outweigh, PDUFA, PE, pertinent, Polytechnic, Pomona, powder, premier, premise, Prescription, proof, reconsider, refuse, replica, Restated, resubmit, resume, Revestive, sensitivity, Shire, smoking, solution, span, stem, stimulate, Takeda, timeline, triple, unchanged, underwent, unsettled, upcoming, User, waive, wealth, worsen, wrong
Removed:
account, accruing, advisor, alleged, anemia, anote, anytime, carryforward, category, classification, complaint, conform, damagesin, dividing, Dutch, eliminated, enable, enhancement, enterprise, forecasted, HB, Historically, hostile, Junior, lieu, motion, nausea, neutropenia, nominal, opposite, permittedunder, pill, plaintiff, poison, predetermined, proportion, put, radiotherapy, randomize, rapidly, reached, securing, takeover, tract, transferred, unspecified, unwinding, vomiting, wholly
Filing tables
Filing exhibits
Related press release
NPSP similar filings
Filing view
External links
NPS PHARMACEUTICALS, INC.
550 Hills Drive, 3rd Floor
Bedminster, New Jersey 07921
February 15, 2012
Securities and Exchange Commission
Washington, D.C. 20549
Ladies and Gentlemen:
Pursuant to the requirements of the Securities Exchange Act of 1934, we are transmitting herewith the attached Form 10-K for the year ended December 31, 2011.
Sincerely,
NPS PHARMACEUTICALS, INC.
Michael J. Golembiewski
Corporate Controller